feed,title,long_url,short_url
BioRxiv,Insights on SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival,https://biorxiv.org/cgi/content/short/2021.02.06.430088v1?rss=1,https://j.mp/3aKt8pu
BioRxiv,The local topological free energy of the SARS-CoV-2 Spike protein,https://biorxiv.org/cgi/content/short/2021.02.06.430094v1?rss=1,https://j.mp/2YWJaXC
BioRxiv,Targeting CTP Synthetase 1 to Restore Interferon Induction and Impede Nucleotide Synthesis in SARS-CoV-2 Infection,https://biorxiv.org/cgi/content/short/2021.02.05.429959v1?rss=1,https://j.mp/3tv71vE
BioRxiv,Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants,https://biorxiv.org/cgi/content/short/2021.02.06.430072v1?rss=1,https://j.mp/3q3Lubm
BioRxiv,A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus macaques,https://biorxiv.org/cgi/content/short/2021.02.07.429299v1?rss=1,https://j.mp/3aMEIQG
BioRxiv,"Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies",https://biorxiv.org/cgi/content/short/2021.02.05.430003v1?rss=1,https://j.mp/3rJsdwv
